Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ALKS-33

Known as: RDC-0313 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Major depressive disorder (MDD) is a common psychiatric disease worldwide. The clinical use of tricyclic antidepressants (TCAs… Expand
Review
2015
Review
2015
Psychopharmacologic treatment is playing a greater role in the management of patients with eating disorders. In this paper, we… Expand
  • table 1
2013
2013
OBJECTIVE To assess preliminarily the effectiveness of a novel opioid antagonist, ALKS-33, in binge eating disorder (BED… Expand
  • table 1
  • figure 1
  • table 3
  • table 2
Review
2011
Review
2011
Introduction: Studies have shown that opioid antagonists like naltrexone are efficient in reducing heavy drinking. The… Expand
2010
2010
  • J. Burt
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 639688
The 240th National Meeting of the American Chemical Society, held in Boston, included topics covering new therapeutic research… Expand